Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dibotermin alfa - Medtronic

Drug Profile

Dibotermin alfa - Medtronic

Alternative Names: Amplify™ rhBMP-2 Matrix; Bone morphogenetic protein-2 - Pfizer/Astellas; InductOs; INFUSE Bone Graft; PF-5208771; rhBMP 2 - Pfizer/Astellas; rhBMP-2/CPM; YM 484

Latest Information Update: 04 Nov 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Wyeth
  • Developer Medtronic Europe; Medtronic Sofamor Danek; Pfizer
  • Class Calcium regulators; Proteins
  • Mechanism of Action Osteogenesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Fracture; Intervertebral disc degeneration
  • Phase II Postmenopausal osteoporosis; Pseudoarthrosis
  • No development reported Bone disorders; Osteoarthritis
  • Discontinued Cancer

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Bone-disorders in Denmark (Implant, Controlled release)
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Osteoarthritis in Denmark (Implant, Controlled release)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top